Hematology Physician

Hematology Physician at Thomas Jefferson University & Jefferson Health summary :

The Hematology Physician at Thomas Jefferson University's SKCC focuses on treating hematologic malignancies and advancing clinical research in the field. Ideal candidates should have an M.D. or D.O. degree, be board eligible or certified in Hematology or Medical Oncology, and possess a passion for education and mentoring in a fast-paced, multidisciplinary clinical environment. The SKCC is a national leader in the development of innovative therapies and provides comprehensive care for patients with complex blood cancers, supported by a robust clinical trials portfolio and a commitment to diversity and excellence in cancer treatment.

The Department of Medical Oncology at Thomas Jefferson University, Sidney Kimmel Cancer Center (SKCC), seeks highly qualified academic physicians in Hematology or Medical Oncology to join the Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation (HMSCT). Candidates must possess an M.D., or D.O. degree, must be BE / BE in Hematology and / or Medical Oncology, and be eligible for a medical license in Pennsylvania.

The ideal candidate will be an outstanding disease-focused early academic physician at the Assistant Professor rank, with a strong focus and some prior experience in clinical research in lymphoma, and potential to build a national reputation as an independent investigator and leader in clinical research. Experience in translational research is of additional interest, but not required. An interest in education and an early track record of mentoring of trainees are also welcome.

The Division of HMSCT, based in center city Philadelphia, comprises faculty that are recognized for excellence in the triple mission of patient care, research and training. Every year, Division faculty and nurses provide complex multidisciplinary and personalized care to hundreds patients with all types of hematologic malignancies, including rare and highly complex blood cancers, attracting referrals nationally and internationally.

The Division is a national leader in the development of new therapies for blood cancers, with a pipeline of clinical trials that is managed by three disease-specific (Lymphoma, Myeloma, and Leukemia / MDS) and one modality-specific (BMT / CART) multidisciplinary disease groups (MDGs) and includes CART- and CAR-NK cell therapies, molecularly targeted therapies, and novel immunotherapies. The Division s clinical trial portfolio is further enhanced by an outstanding Phase I program, in academic partnership with the Sarah Cannon Research Institute (SCRI), and a strong and innovative Health Delivery Research group.

The SKCC is an NCI-designated consortium cancer center that includes researchers from Thomas Jefferson University and Drexel University and offers outstanding shared core facilities. The SKCC is located in the heart of Philadelphia, a vibrant urban cultural scene with an abundance of opportunities for professional and social interactions. Jefferson values diversity and encourages applications from women, members of minority groups, LGBTQ individuals, disabled individuals, and veterans.

Jefferson Health offers full benefits including excellent medical coverage, retirement options 403b & pension malpractice coverage and many other options.

Keywords :

Hematology, Medical Oncology, Hematologic Malignancies, Clinical Trials, Cancer Research, Patient Care, Stem Cell Transplantation, Lymphoma, Immunotherapy, Education and Mentoring